Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Document › Details

Medigene AG. (7/10/14). "Press Release: Medigene AG Confirms Final Subscription Price for New Shares and Final Conversion Price for Convertible Bonds [Not for release, publication or distribution in the United States, Canada, Japan or Australia]". Martin

Organisation Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
Products Product T cell therapy
  Product 2 investment banking
Index terms Index term Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds
  Index term 2 Trianta Immunotherapies–Medigene: investment, 201401 acquisition 100% for 1m shares worth €4m plus €5.875m milestones in shares or cash
     


   
Record changed: 2017-04-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top